Zuplenz oral soluble film approved for nausea and vomiting - MPR

Links shared publicly online about this topic.

  • 1,042
    total visits

Zuplenz oral soluble film approved for nausea and vomiting - MPR

empr.com

The FDA has approved Zuplenz (ondansetron oral soluble film, from Strativa) for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting.

View full resource at empr.com

Tags: Nausea, Vomiting, Nausea and Vomiting Medication, Cancer, FDA, Zofran

  • Share

Most Recently Shared on July 6, 2010 at 3:33 pm By:

eMPR MPR

MPR News: Zuplenz oral soluble film approved for nausea and vomiting: The FDA has approved Zuplenz (ondansetron or... http://bit.ly/aXywsA

2 years ago...

MonoSol Rx Announces FDA Approval Of Zuplenz(R) Oral Soluble Film For Treatment Of Nausea And Vomiting

medicalnewstoday.com — “MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical products, in collaboration with APR Applied Pharma Research s.a. of SwitzerlView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on July 9, 2010 at 2:05 pm By:

mnt_drugapprov MNT Drug Approvals Health News

MonoSol Rx Announces FDA Approval Of Zuplenz(R) Oral Soluble Film For Treatment Of Nausea And Vomiting http://mnt.to/3FSS #regulatory

2 years ago...

FDA Approves Strativa Pharmaceuticals' Zuplenz (ondansetron) Oral Soluble Film

drugs.com — “Zuplenz (ondansetron) is used to prevent chemotherapy-induced, radiotherapy-induced, and postoperative nausea and vomiting. Includes Zuplenz side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on July 7, 2010 at 9:12 am By:

drugscom Drugs.com Health Site

FDA Approves Strativa Pharmaceuticals' Zuplenz (ondansetron) Oral Soluble Film - http://bit.ly/c0E35U

2 years ago...

Strativa receives FDA approval for Zuplenz oral soluble film

news-medical.net — “Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 3, 2010 at 5:03 am By:

NewsMedical News-Medical.Net Health News

Strativa receives FDA approval for Zuplenz oral soluble film: Strativa Pharmaceuticals today announced that the U.... http://bit.ly/94H7c7

2 years ago...

Advertisement